Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 360
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Br J Dermatol ; 183(5): 831-839, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32198756

RESUMO

BACKGROUND: Taxanes are the current first-line treatment for advanced cutaneous angiosarcoma (CAS) for patients who are considered difficult to treat with doxorubicin owing to advanced age or comorbidity. However, no effective second-line therapy for such patients has been established. METHODS: We designed a single-arm prospective observational study of eribulin mesylate (ERB) administered at a dose of 1·4 mg m-2 on days 1 and 8 in a 21-day cycle. Patients with advanced CAS who were previously treated with a taxane and were scheduled to begin ERB treatment were enrolled. The primary endpoint was overall survival (OS) and the secondary endpoints were response rate (RR), progression-free survival (PFS) and toxicity assessment. RESULTS: We enrolled a total of 25 patients. The median OS and PFS were 8·6 months and 3·0 months, respectively. The best overall RR was 20% (five of 25). In total, 16 grade 3/4 severe adverse events (SAEs) occurred; however, all patients recovered. Patients who achieved partial response or stable disease as best response had longer OS than those with progressive disease (median OS not reached and 3·3 months, respectively; P < 0·001). Patients who did not experience SAEs showed longer OS than those who did (median OS 18·8 months and 7·5 months, respectively; P < 0·05). Patients with distant metastasis had shorter median OS than those with locoregional disease, but without statistically significant difference. CONCLUSIONS: ERB showed a promising RR and is a potential candidate for second-line treatment for patients with CAS, after treatment with taxanes. However, owing to the occurrence of SAEs in over half of the participants, caution should be exercised regarding ERB use in elderly patients. What is already known about this topic? Taxanes are the current first-line treatment for patients with advanced cutaneous angiosarcoma (CAS) who are considered difficult to treat with doxorubicin owing to advanced age or comorbidity. No effective therapy for taxane-resistant CAS has been established thus far. Eribulin suppresses microtubule polymerization and elicits an antitumour effect similar to that of taxanes. What does this study add? In our single-arm prospective observational study to evaluate the efficacy of eribulin for treating patients with advanced CAS who previously received taxanes, the median overall survival and progression-free survival were 8·6 and 3·0 months, respectively. Response rates at weeks 7, 13 and 25 were 20%, 17% and 14%, respectively. Although 16 grade 3/4 severe adverse events occurred, all patients recovered. Eribulin showed a promising response rate and is a potential candidate for second-line treatment in CAS after taxane treatment. Linked Comment: Smrke and Benson. Br J Dermatol 2020; 183:797-798.


Assuntos
Neoplasias da Mama , Hemangiossarcoma , Idoso , Neoplasias da Mama/tratamento farmacológico , Hidrocarbonetos Aromáticos com Pontes , Furanos , Hemangiossarcoma/tratamento farmacológico , Humanos , Cetonas , Taxoides , Resultado do Tratamento
2.
BMC Cancer ; 19(1): 912, 2019 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-31510956

RESUMO

BACKGROUND: Interaction between cancer cells and fibroblasts mediated by extracellular matrix metalloproteinase inducer (emmprin, CD147) is important in the invasion and proliferation of cancer cells. However, the exact mechanism of emmprin mediated stimulation of matrix metalloprotease-2 (MMP-2) production from fibroblasts has not been elucidated. Our previous studies using an inhibitory peptide against emmprin suggested the presence of a molecule on the cell membrane which forms a complex with emmprin. Here we show that CD73 expressed on fibroblasts interacts with emmprin and is a required factor for MMP-2 production in co-cultures of sarcoma cells with fibroblasts. METHODS: CD73 along with CD99 was identified by mass spectrometry analysis as an emmprin interacting molecule from a co-culture of cancer cells (epithelioid sarcoma cell line FU-EPS-1) and fibroblasts (immortalized fibroblasts cell line ST353i). MMP-2 production was measured by immunoblot and ELISA. The formation of complexes of CD73 with emmprin was confirmed by immunoprecipitation, and their co-localization in tumor cells and fibroblasts was shown by fluorescent immunostaining and proximity ligation assays. RESULTS: Stimulated MMP-2 production in co-culture of cancer cells and fibroblasts was completely suppressed by siRNA knockdown of CD73, but not by CD99 knockdown. MMP-2 production was not suppressed by CD73-specific enzyme inhibitor (APCP). However, MMP-2 production was decreased by CD73 neutralizing antibodies, suggesting that CD73-mediated suppression of MMP-2 production is non-enzymatic. In human epithelioid sarcoma tissues, emmprin was immunohistochemically detected to be mainly expressed in tumor cells, and CD73 was expressed in fibroblasts and tumor cells: emmprin and CD73 were co-localized predominantly on tumor cells. CONCLUSION: This study provides a novel insight into the role of CD73 in emmprin-mediated regulation of MMP-2 production.


Assuntos
5'-Nucleotidase/metabolismo , Basigina/metabolismo , Metaloproteinase 2 da Matriz/metabolismo , Biomarcadores , Linhagem Celular Tumoral , Técnicas de Cocultura , Fibroblastos , Proteínas Ligadas por GPI/metabolismo , Humanos , Imuno-Histoquímica , Espectrometria de Massas , Modelos Biológicos , Proteômica/métodos
3.
Br J Dermatol ; 177(6): 1726-1731, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-27873302

RESUMO

'Pseudoprogression' is often seen in patients with melanomas who are treated with immune checkpoint inhibitors such as nivolumab or ipilimumab. We sometimes evaluate metastatic lesions by imaging tests such as computed tomography (CT) or positron emission tomography-CT. 'Pseudoprogression' usually occurs upon the initial administration, which may make it difficult for the physician to determine the disease condition. In our two cases of metastatic melanoma treated with nivolumab (antiprogrammed cell death-1 antibody), we examined the ultrasonography (US) of target lesions that could be accessed from the body surface, such as those of the regional lymph node or subcutaneous metastasis. In both cases, the US revealed a lesion approximately 10% greater in size after 40-50 days of nivolumab administration, even though the blood flow inside the tumour was reduced by about 20% within 50 days. From about 100 days after blood flow reduction was detected by US, the tumours began to decrease in size. However, contrast CT was unable to detect the association between tumour size and tumour blood flow. The present cases suggest that US could be a powerful tool for differentiating between 'pseudoprogression' and real progressive disease in patients treated with cancer immunotherapies such as those involving immune checkpoint inhibitors. The misdiagnosis of progressive disease can lead to unnecessary alterations to the current treatment. Therefore, the US findings in our study could be clinically useful and educational for physicians.


Assuntos
Antineoplásicos Imunológicos/administração & dosagem , Melanoma/tratamento farmacológico , Nivolumabe/administração & dosagem , Neoplasias Cutâneas/tratamento farmacológico , Idoso , Idoso de 80 Anos ou mais , Progressão da Doença , Esquema de Medicação , Feminino , Humanos , Metástase Linfática , Melanoma/diagnóstico por imagem , Metástase Neoplásica , Neoplasias Cutâneas/diagnóstico por imagem , Resultado do Tratamento , Ultrassonografia
4.
Clin Exp Dermatol ; 42(7): 781-785, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28649738

RESUMO

Interferon (IFN)-alfa as an adjuvant therapy has been found to improve relapse-free survival in patients with malignant melanoma (MM). However, the efficacy of IFN-beta has not been studied in detail. This study evaluated the contribution of adjuvant IFN-beta therapy to improvements in the prognosis of patients with MM. We reviewed 63 patients with resected stage II/III primary MM at our institution. Of these, 36 had been treated with IFN-beta adjuvant therapy (subcutaneous injection, 3 × 106 IU/day, 10 days), while 27 patients had undergone observation alone. In comparisons of all patients (stage II/III), overall survival and relapse-free survival were significantly better in the IFN-beta group than in the observation group (P < 0.001 for both). The 75-month overall survival rate was 41.2% in the observation group and 68.7% in the IFN-beta group. Adjuvant therapy with IFN-beta may become a new treatment option for patients with stage II/III MM.


Assuntos
Antineoplásicos/uso terapêutico , Interferon beta/uso terapêutico , Melanoma/tratamento farmacológico , Neoplasias Cutâneas/tratamento farmacológico , Idoso , Quimioterapia Adjuvante , Intervalo Livre de Doença , Feminino , Humanos , Injeções Subcutâneas , Estimativa de Kaplan-Meier , Masculino , Melanoma/mortalidade , Melanoma/cirurgia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Prognóstico , Estudos Retrospectivos , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/cirurgia , Taxa de Sobrevida
5.
Clin Exp Dermatol ; 42(5): 523-526, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28543586

RESUMO

Phototherapy is a useful noninvasive therapy, but it can induce cutaneous malignant tumours, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We report on a 79-year-old man who had long-standing mycosis fungoides for 40 years, which had been treated with psoralen ultraviolet A therapy for 37 years at a dose of approximately 5000 J/cm2 . Approximately 6 years before presentation, numerous types of cutaneous malignancies, including actinic keratosis, BCC and SCC, had begun to develop all over the patient's body. We hypothesized that he was experiencing a pathogenesis similar to patients with xeroderma pigmentosum (XP), and we therefore assessed his DNA repair capacity. Based on these investigations, the patient was eventually diagnosed as non-XP, even though we detected that his DNA repair capacity was slightly lower than that of normal controls, which may have led to the skin cancers. We speculate that multiple skin malignancies can be induced by long-term phototherapy in patients with slightly impaired DNA repair capacity.


Assuntos
Distúrbios no Reparo do DNA/diagnóstico , Micose Fungoide/radioterapia , Neoplasias Induzidas por Radiação , Neoplasias Cutâneas/patologia , Terapia Ultravioleta/efeitos adversos , Idoso , Carcinoma Basocelular/etiologia , Carcinoma Basocelular/patologia , Carcinoma de Células Escamosas/etiologia , Distúrbios no Reparo do DNA/complicações , Humanos , Masculino , Melanoma/etiologia , Melanoma/patologia , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/radioterapia
6.
Phys Rev Lett ; 117(3): 037204, 2016 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-27472134

RESUMO

We report the experimental observation of Snell's law for magnetostatic spin waves in thin ferromagnetic Permalloy films by imaging incident, refracted, and reflected waves. We use a thickness step as the interface between two media with different dispersion relations. Since the dispersion relation for magnetostatic waves in thin ferromagnetic films is anisotropic, deviations from the isotropic Snell's law known in optics are observed for incidence angles larger than 25° with respect to the interface normal between the two magnetic media. Furthermore, we can show that the thickness step modifies the wavelength and the amplitude of the incident waves. Our findings open up a new way of spin wave steering for magnonic applications.

7.
Br J Dermatol ; 174(2): 395-7, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26285645

RESUMO

Mucin core protein (MUC) 5AC is a gel-forming glycoprotein that is expressed in different types of tumour cells. MUC5AC expression in cultured cells is regulated through the extracellular matrix and through remodelling by other membranous proteins such as type IV collagen (COL4) and E-cadherin. However, it has not been elucidated whether COL4 and E-cadherin affect MUC5AC expression in tumours in vivo. Here, by analysing a single individual with concomitant neoplasms in the skin [extramammary Paget disease (EMPD)] and the stomach (gastric cancer), we show that MUC5AC expression is reduced in COL4 and membranous E-cadherin-expressing EMPD specimens whereas MUC5AC is not abolished in gastric cancer with COL4 negativity and E-cadherin cytoplasmic localization. As the EMPD and gastric cancer specimens were derived from a single patient, each specimen had the same genetic background. These in vivo results support previous in vitro studies which showed that COL4 and E-cadherin downregulated MUC5AC expression. Our study suggests that concomitant neoplasms in different organs of the same individual can serve as a strong tool for uncovering functional diversity in tumour markers in distinct cancer cells.


Assuntos
Biomarcadores Tumorais/metabolismo , Caderinas/fisiologia , Colágeno Tipo IV/fisiologia , Neoplasias Cutâneas/metabolismo , Neoplasias Gástricas/metabolismo , Idoso , Regulação para Baixo/fisiologia , Humanos , Masculino , Mucina-5AC/metabolismo , Neoplasias Primárias Múltiplas/metabolismo , Doença de Paget Extramamária/metabolismo , Neoplasias Penianas/metabolismo
9.
Dis Aquat Organ ; 122(1): 13-19, 2016 11 22.
Artigo em Inglês | MEDLINE | ID: mdl-27901500

RESUMO

Cymothoid isopods (family Cymothoidae) are commonly found parasitizing diverse fishes, including commercial species. However, the effects of these parasites on host body condition are still poorly known. Here we investigated the spatial variation of the effects of parasite infection on host body condition, using the parasitic load of the cymothoid Mothocya parvostis on the Japanese halfbeak Hyporhamphus sajori at 4 sampling sites in western Japan. M. parvostis prevalence at each site (41.6-74.4%) was higher than that known for other fish host-cymothoid systems (usually less than 30%). The number of isopods in infected hosts, the reproductive status of female isopods (i.e. ovigerous/non-ovigerous), and the body size of female and male isopods relative to the size of their hosts were not significantly different among sites. However, at the site where human activity was most intense, M. parvostis infection had a significantly negative effect on host body condition. These results suggest that the effect of cymothoid infection on host body condition might be benign under natural conditions but becomes detrimental in habitats that are unsuitable for the host, such as highly human-impacted areas.


Assuntos
Ectoparasitoses/veterinária , Doenças dos Peixes/parasitologia , Peixes , Isópodes , Animais , Ectoparasitoses/epidemiologia , Ectoparasitoses/parasitologia , Feminino , Doenças dos Peixes/epidemiologia , Japão/epidemiologia , Masculino
10.
Br J Dermatol ; 173(5): 1263-5, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26147882

RESUMO

Primary mucinous carcinoma of the skin (PMCS) is a rare cutaneous malignant neoplasm; its regional node metastasis is also rare. Currently, positron emission tomography-computed tomography (PET-CT) is known to be a useful tool to search for early metastatic lesions in various carcinomas. However, PET-CT is not always specific for head and neck lesions because of physiological uptake in the brain, palatine tonsil, salivary gland, thyroid etc. Herein we present two cases of head and neck PMCS in which metastasis was diagnosed accurately by PET-CT. In these cases, nodal uptake of fluorodeoxy-d-glucose (FDG) histopathologically proved PMCS metastasis, verifying the utility of PET-CT in detail. A surgeon was involved in the verification to compare the histopathological manifestations with the imaging results. Histopathologically, two of 13 nodes were positive in case 1, and one of 41 nodes was positive in case 2. These positive nodes were completely in accordance with the FDG uptake findings with no false negative findings. In treating PMCS on head and neck lesions, PET-CT may be useful in the preoperative assessment when planning the extent of resection.


Assuntos
Adenocarcinoma Mucinoso/diagnóstico , Neoplasias de Cabeça e Pescoço/diagnóstico , Tomografia por Emissão de Pósitrons/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Detecção Precoce de Câncer , Feminino , Fluordesoxiglucose F18 , Humanos , Metástase Linfática , Masculino , Imagem Multimodal/métodos , Compostos Radiofarmacêuticos
11.
Br J Dermatol ; 172(3): 769-73, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25066310

RESUMO

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe hereditary mechanobullous disease resulting from mutations in the COL7A1 gene, coding for type VII collagen. Patients with RDEB tend to develop squamous cell carcinomas (SCCs) at sites of chronic ulceration or scarring on the whole body. Distinguishing SCC from benign hyperkeratotic lesions is often difficult, not only clinically but also histologically in patients with RDEB. We investigated several matrix metallopeptidase (MMP) subtypes by comparing the DNA amplification microarray findings between evident SCCs and benign hyperkeratotic lesions in the same patient with RDEB. We report that MMP13 was found to be strongly positive in SCCs but negative in benign hyperkeratotic lesions. We found that there is an evident difference in the transitional area between SCCs and benign hyperkeratotic lesions. We propose that MMP13 may be a useful differentiating marker between SCC and benign hyperkeratotic lesions in RDEB.


Assuntos
Carcinoma de Células Escamosas/diagnóstico , Epidermólise Bolhosa Distrófica/complicações , Ceratose/diagnóstico , Metaloproteinase 13 da Matriz/metabolismo , Neoplasias Cutâneas/diagnóstico , Adulto , Biomarcadores/metabolismo , Carcinoma de Células Escamosas/complicações , Diagnóstico Diferencial , Feminino , Humanos , Ceratose/complicações , Neoplasias Cutâneas/complicações
13.
Oral Dis ; 21(5): 645-51, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25704085

RESUMO

OBJECTIVE: Roles of aging or immune responses mediated by Toll-like receptors and natural killer cell in the onset or progression of human candidiasis remain unclear. This study was designed to elucidate the roles using peripheral blood mononuclear cells from healthy donors and patients with oral candidiasis. SUBJECTS AND METHODS: Subjects tested were healthy volunteers and patients who visited Dental Clinical Division of Hokkaido University Hospital. The patients with oral candidiasis included 39 individuals (25-89 years of age) with major complaints on pain in oral mucosa and/or dysgeusia. Healthy volunteers include students (25-35 years of age) and teaching staffs (50-65 years of age) of Hokkaido University Graduate School of Dental Medicine. RESULTS: Functions of Toll-like receptors 2 and 4 were downregulated significantly and the natural killer activity was slightly, but not significantly downregulated in aged healthy volunteers compared with healthy young volunteers. Functions of Toll-like receptors 2 and 4 and the natural killer activity were significantly downregulated in patients with oral candidiasis compared with healthy volunteers. CONCLUSION: Downregulation of functions of Toll-like receptors 2 and 4 as well as natural killer activity is suggested to be associated with the onset or progression of oral candidiasis in human.


Assuntos
Candidíase Bucal/imunologia , Células Matadoras Naturais/imunologia , Células Matadoras Naturais/metabolismo , Receptores Toll-Like/biossíntese , Receptores Toll-Like/imunologia , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Candida albicans/isolamento & purificação , Candidíase Bucal/microbiologia , Progressão da Doença , Regulação para Baixo , Feminino , Citometria de Fluxo , Humanos , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Masculino , Pessoa de Meia-Idade , Receptores Toll-Like/metabolismo
14.
J Eur Acad Dermatol Venereol ; 29(5): 1015-8, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-24911929

RESUMO

BACKGROUND: Lenticular island pedicle flap (LIPF) has been reported to be one of the most useful techniques for reconstructing middle cheek skin defects. LIPF may have been used all over the world on a daily basis; however, no reports have examined a large number of LIPF cases at a single institution. MATERIALS AND METHODS: A total of 28 cases of reconstruction by LIPF at the Hokkaido University Hospital from 2005 to 2013 were analysed. We examined the tumour type, location, area of defect and presence/absence of antithrombotic treatment and complications, including transient circulatory impairment, damage to facial nerves and eyelid ectropion. RESULTS: We found that nine patients had transiently impaired circulation. This complication was statistically more frequent in the patients without antithrombotic treatment than in the patients with antithrombotic treatment (0/8 vs. 10/20, P = 0.0292; Fisher's exact test). CONCLUSION: We revelled that LIPF have been safely performed even under antithrombotic treatment, so, when patients are taking antithrombotic agents, we should choose LIPF rather than conventional flap including cheek flap, island pedicle flap and so on.


Assuntos
Adenocarcinoma Mucinoso/cirurgia , Carcinoma Basocelular/cirurgia , Procedimentos Cirúrgicos Dermatológicos/métodos , Neoplasias Faciais/cirurgia , Sarda Melanótica de Hutchinson/cirurgia , Neoplasias Cutâneas/cirurgia , Retalhos Cirúrgicos , Idoso , Idoso de 80 Anos ou mais , Bochecha , Procedimentos Cirúrgicos Dermatológicos/efeitos adversos , Feminino , Fibrinolíticos/efeitos adversos , Humanos , Isquemia/induzido quimicamente , Masculino , Pessoa de Meia-Idade , Retalhos Cirúrgicos/irrigação sanguínea
17.
J Eur Acad Dermatol Venereol ; 28(6): 727-32, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23581859

RESUMO

BACKGROUND: Patients with in situ extramammary Paget's disease (EMPD) tend to have a good prognosis, although dermal invasion and metastasis are associated with significantly increased morbidity and mortality. Previous studies have addressed mechanisms underlying the EMPD pathogenesis; however, no molecular markers that reflect invasiveness or progression have been established. OBJECTIVE: This study aims to identify a reliable marker for predicting the risk of invasion and metastasis in EMPD. METHODS: We performed an initial microarray screening for in situ, invasive or metastatic lymph node lesions of EMPD. We analysed 44 specimens from 38 primary EMPD cases by immunohistochemical staining. RESULTS: We found that expressions of MUC5AC directly correlate with invasion and prognosis. Labelling rates of tumour cells were scored by staining intensity on a four-tiered scale (- to 3+) to investigate the correlation between the expression score of these molecular markers and the type of EMPD lesion. All the specimens scored positive (3+) for MUC1 and negative (-) for MUC6. MUC5AC expression was detected in 19 of 44 (43.2%) specimens. Invasive lesions and metastatic lymph nodes tended to express MUC5AC significantly higher than in situ lesions (P < 0.01). MUC2 was positive in 10 specimens (22.7%). There was no significant difference between the degree of MUC2 expression and invasiveness. CONCLUSION: The degree of MUC5AC expression may correlate with the invasiveness and progression of EMPD, and may be a useful marker for identifying high-risk EMPD cases.


Assuntos
Biomarcadores Tumorais/genética , Mucina-5AC/genética , Doença de Paget Extramamária/genética , Doença de Paget Extramamária/patologia , Idoso , Idoso de 80 Anos ou mais , Progressão da Doença , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Metástase Neoplásica , Medição de Risco
18.
Br J Cancer ; 108(1): 170-8, 2013 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-23321518

RESUMO

BACKGROUND: Cancer cells utilise the glycolytic pathway even when adequate oxygen is present, a phenomenon known as the Warburg effect. We examined whether this system is operative in multiple myeloma (MM) cells and whether glycolysis inhibition is a potential therapeutic modality. METHODS: The MM cells were purified from 59 patients using CD138-immunomagnetic beads. The expression levels of genes associated with glycolysis, c-MYC, GLUT1, LDHA, HIF1A and pyruvate dehydrogenase kinase-1 (PDK1) were determined by real-time PCR. Glucose consumption and lactate production by MM cell lines were analysed. Oxamate, an LDH inhibitor, and dichloroacetate (DCA), a PDK1 inhibitor, were employed. Inhibition of PDK1 expression was achieved using a siRNA. RESULTS: High LDHA expression was found to be an indicator of poor prognosis. It was also positively correlated with the expression of PDK1, c-MYC and GLUT1. Greater glucose consumption and lactate production in MM cells was associated with higher LDHA expression. All the glycolysis inhibitors (oxamate, DCA and PDK1 siRNA) induced apoptosis in MM cells. DCA combined with bortezomib showed additive cytotoxic effects. CONCLUSION: The present data suggest that the Warburg effect is operative in MM cells. As PDK1 is not overexpressed in normal tissues, PDK1 inhibition could serve as a novel therapeutic approach.


Assuntos
Mieloma Múltiplo/tratamento farmacológico , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Ácidos Borônicos/farmacologia , Bortezomib , Linhagem Celular Tumoral , Ácido Dicloroacético/farmacologia , Glucose/metabolismo , Glicólise/efeitos dos fármacos , Humanos , Lactato Desidrogenases , Ácido Láctico/biossíntese , Terapia de Alvo Molecular , Mieloma Múltiplo/enzimologia , Mieloma Múltiplo/genética , Proteínas Serina-Treonina Quinases/genética , Pirazinas/farmacologia , Piruvato Desidrogenase Quinase de Transferência de Acetil , RNA Interferente Pequeno/farmacologia
20.
Br J Dermatol ; 168(1): 206-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22834455

RESUMO

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic follicular occlusive disease with characteristic recurrent draining sinuses, skin abscesses and disfiguring scars, mainly involving the axilla, groin, perianal and perineal regions. While most HS cases are nonfamilial, familial cases showing autosomal dominant inheritance have been reported. Recently, loss-of-function mutations in the genes encoding γ-secretase have been identified as a cause of familial HS in the Chinese and British populations. OBJECTIVES: To identify mutations in the genes encoding γ-secretase in Japanese patients with familial and nonfamilial HS. METHODS: Two affected and three unaffected individuals from a Japanese family with familial HS and nine patients with nonfamilial HS were recruited. We conducted mutation analysis of the γ-secretase genes in Japanese patients with familial and nonfamilial HS. RESULTS: A novel splice site mutation in the nicastrin gene NCSTN, one of the six key component genes encoding γ-secretase, was identified in the patients with familial HS. Neither unaffected individuals in the family nor 100 ethnically matched control alleles carry this mutation. None of the nine patients with nonfamilial HS carry nonsense, frameshift or splice site mutations in this gene. CONCLUSIONS: A novel splice site mutation, c.582+1delG, in NCSTN was identified in the familial patients with HS. We also reveal for the first time that a γ-secretase gene mutation is not linked to the development of nonfamilial HS. These results would further pave the way to a better understanding of the contribution of γ-secretase and other genes to the pathogenesis of HS and to the development of a new therapeutic strategy for HS.


Assuntos
Secretases da Proteína Precursora do Amiloide/genética , Hidradenite Supurativa/genética , Glicoproteínas de Membrana/genética , Mutação/genética , Sítios de Splice de RNA/genética , Estudos de Casos e Controles , Feminino , Heterozigoto , Humanos , Japão , Masculino , Linhagem , Polimorfismo de Nucleotídeo Único/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA